Objectives: The purpose of this study was to create, standardize, and validate a new instrument, named 4-DSD, and determine its diagnostic accuracy in the diagnosis of delirium in subjects with moderate to severe dementia. Design: Multicenter cross-sectional observational study. Setting and Participants: Older patients consecutively admitted to acute and rehabilitation hospital wards. Measures: The DSM-5 was used as the reference standard delirium assessment. The presence and severity of dementia was defined using the AD8 and the Global Deterioration Scale (GDS). The 4-DSD is a 4-item tool that ranges from 0 to 12. Item 1 measures alertness, item 2 altered function, item 3 attention, and item 4 acute change or fluctuation in mental status. Results: A total of 134 patients were included in the study. Most of the patients were enrolled in acute hospital wards (60%), with 40% in rehabilitation settings. A minority of the patients were categorized with moderate dementia, with a GDS score of 5 (4%). Most of the patients were in the moderate-severe stage with a GDS score ≤6 (77%); 19% were classed as severe, with a GDS score of 7. A 4-DSD cutoff score ≥5 had a sensitivity of 80% and specificity of 80% with a positive predictive value (PPV) of 67% and a negative predictive value (NPV) of 89%. In the subgroup with moderate-severe dementia (n = 108), the sensitivity and the specificity were 79% and 82%, respectively, with a PPV and NPV of 62% and 92%. In the subgroup with severe dementia (n = 26) the sensitivity was 82% and the specificity 56% with a PPV of 78% and a NPV of 63%. Conclusions and Implications: The availability of a specific tool to detect delirium in patients with moderate-severe dementia has important clinical and research implications, allowing all health care providers to improve their ability to identify it.

The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia / Morandi A.; Grossi E.; Lucchi E.; Zambon A.; Faraci B.; Severgnini J.; MacLullich A.; Smith H.; Pandharipande P.; Rizzini A.; Galeazzi M.; Massariello F.; Corradi S.; Raccichini A.; Scrimieri A.; Morichi V.; Gentile S.; Lucchini F.; Pecorella L.; Mossello E.; Cherubini A.; Bellelli G.. - In: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. - ISSN 1525-8610. - ELETTRONICO. - 22:(2021), pp. 1535-1542. [10.1016/j.jamda.2021.02.029]

The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia

Lucchini F.;Pecorella L.;Mossello E.;
2021

Abstract

Objectives: The purpose of this study was to create, standardize, and validate a new instrument, named 4-DSD, and determine its diagnostic accuracy in the diagnosis of delirium in subjects with moderate to severe dementia. Design: Multicenter cross-sectional observational study. Setting and Participants: Older patients consecutively admitted to acute and rehabilitation hospital wards. Measures: The DSM-5 was used as the reference standard delirium assessment. The presence and severity of dementia was defined using the AD8 and the Global Deterioration Scale (GDS). The 4-DSD is a 4-item tool that ranges from 0 to 12. Item 1 measures alertness, item 2 altered function, item 3 attention, and item 4 acute change or fluctuation in mental status. Results: A total of 134 patients were included in the study. Most of the patients were enrolled in acute hospital wards (60%), with 40% in rehabilitation settings. A minority of the patients were categorized with moderate dementia, with a GDS score of 5 (4%). Most of the patients were in the moderate-severe stage with a GDS score ≤6 (77%); 19% were classed as severe, with a GDS score of 7. A 4-DSD cutoff score ≥5 had a sensitivity of 80% and specificity of 80% with a positive predictive value (PPV) of 67% and a negative predictive value (NPV) of 89%. In the subgroup with moderate-severe dementia (n = 108), the sensitivity and the specificity were 79% and 82%, respectively, with a PPV and NPV of 62% and 92%. In the subgroup with severe dementia (n = 26) the sensitivity was 82% and the specificity 56% with a PPV of 78% and a NPV of 63%. Conclusions and Implications: The availability of a specific tool to detect delirium in patients with moderate-severe dementia has important clinical and research implications, allowing all health care providers to improve their ability to identify it.
2021
22
1535
1542
Goal 3: Good health and well-being for people
Morandi A.; Grossi E.; Lucchi E.; Zambon A.; Faraci B.; Severgnini J.; MacLullich A.; Smith H.; Pandharipande P.; Rizzini A.; Galeazzi M.; Massariello F.; Corradi S.; Raccichini A.; Scrimieri A.; Morichi V.; Gentile S.; Lucchini F.; Pecorella L.; Mossello E.; Cherubini A.; Bellelli G.
File in questo prodotto:
File Dimensione Formato  
Delirium4-DSDMorandi.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 1.45 MB
Formato Adobe PDF
1.45 MB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1247281
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact